GGrantIndex
Sort

40,608 grants matching prostate cancer

Role of Novel Cytokine-like Molecule Secretoglobin (SCGB) 3A2 in Lung

$750,711
Shioko Kimura · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Chemoprevention of Prostate Cancer, HDAC Inhibition, and DNA Methylation

$750,639
Emily Ho · Oregon State University · P01 · FY2012 · CA

Enabling Technologies for MRI-Guided Prostate Interventions

$750,573
Clare M Tempany · Brigham And Women'S Hospital · R01 · FY2009 · CA

GENE-ENVIRONMENT INTERACTION IN PROSTATE CANCER

$750,497
Henry Ford Health System · R01 · FY2004 · ES

Long-term health consequences of birth by cesarean section

$750,369
Jorge Eduardo Chavarro · Harvard School Of Public Health · R01 · FY2018 · HD

Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways

$750,245
Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion

$750,245
Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion

$750,182
Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways

$750,182
Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Synthesis of Antitumor Natural Products

$750,028
Samuel J Danishefsky · Sloan-Kettering Inst Can Research · R37 · FY2008 · CA

Vaccine and radiation for the therapy of human cancers

$750,008
James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Vaccine and Drug Combination Therapy for Human Cancers

$750,008
James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

PHASE III TRIAL OF SELENIUM FOR PROSTATE CANCER PREVENT

$750,000
University Of Arizona · R01 · FY2004 · CA

QUALITY RESEARCH IN RADIATION ONCOLOGY: ACR PCS

$750,000
Jesse F Wilson · American College Of Radiology · R01 · FY2006 · CA

Single-cell phenotyping for therapeutic stratification in pancreatic cancer

$750,000
Denis Wirtz · Johns Hopkins University · R01 · FY2016 · CA

Role of FGFR1 signaling in distinct cell lineages in prostate cancer progresssion

$750,000
David M Spencer · Baylor College Of Medicine · U01 · FY2009 · CA

Enabling Point of Care Screening for Sepsis Using Rapid Single Cell Analysis

$750,000
Ajay Shah · Cytovale, Inc. · R44 · FY2016 · HL

Single-cell phenotyping for therapeutic stratification in pancreatic cancer

$750,000
Denis Wirtz · Johns Hopkins University · R01 · FY2015 · CA

NRG ONCOLOGY NETWORK GROUP OPERATIONS CENTER

$750,000
Norman Wolmark · Nrg Oncology Foundation, Inc. · U10 · FY2016 · CA

Single-cell phenotyping for therapeutic stratification in pancreatic cancer

$750,000
Denis Wirtz · Johns Hopkins University · R01 · FY2012 · CA

A Phase II trial of abiraterone in combination with PDMX1001 in enzalutamide-resistant prostate cancer

$750,000
Chengfei Liu · Pandomedx, Inc. · R44 · FY2019 · CA

Single-cell phenotyping for therapeutic stratification in pancreatic cancer

$750,000
Denis Wirtz · Johns Hopkins University · R01 · FY2014 · CA

RSK2 IN PROSTATE CANCER

$750,000
The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2009 · Department of the Army

Single-cell phenotyping for therapeutic stratification in pancreatic cancer

$750,000
Denis Wirtz · Johns Hopkins University · R01 · FY2013 · CA

BAK-LOSS LETHAL PROSTATE CANCER: UNCOVERING THERAPEUTIC VULNERABILITIES TO DELIVER NEW TREATMENTS AND IMPROVE CLINICAL OUTCOMES

$749,996
Institute Of Cancer Research: Royal Cancer Hospital (The) · · FY2025 · Defense Health Agency